Informação sobre produto
- Pyrazolo[1,5-a]pyrimidin-7-amine, 3-(4-methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]-
- NBI 77860
- 3-(4-Methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]pyrazolo[1,5-a]pyrimidin-7-amine
- GSK 561679A
Verucerfont is a drug that binds to the glucocorticoid receptor and inhibits transcription. It has been shown to have potent anti-inflammatory effects in mouse models of inflammatory diseases, such as arthritis and colitis, by inhibiting cytokine production. Verucerfont also potently inhibits the synthesis of proinflammatory cytokines in human cells, including IL-1β, IL-6, and TNFα. Verucerfont has not been shown to be effective for treating inflammatory diseases in women.
Propriedades químicas
Consulta técnica sobre: 3D-KKB22061 Verucerfont
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.